Advanced search×

[Disposal of waste containing asbestos in Croatia].

Vinko V Mladineo

Arh Hig Rada Toksikol (2009) PMID 20853773

In order to ensure systematic disposal of asbestos waste in the whole of Croatia, its government has mandated the Environmental Protection and Energy Efficiency Fund to implement emergency measures to collect and dispose of asbestos-containing construction waste. This requires a construction of 45 special disposal containers in the existing municipal waste landfills and contracting collection of asbestos-containing construction waste. By now, the Fund has disposed of 8000 m3 of asbestos cement waste, recovered five dumps with asbestos-containing construction waste, reclaimed a location contaminated by asbestos in Vranjic, and has continued to recover the land at the premises of factory Salonit in bankruptcy, which had been producing corrugated asbestos sheets before the ban. In collaboration with several non-governmental organisations, the Fund has started an educational campaign to protect the environment.

Version: za2963e q8za6 q8zbc q8zc2 q8zd9 q8ze1 q8zf3 q8zg3
PDF not found

Similar articles you may find interesting…

  1. RemA is a DNA-binding protein that activates biofilm matrix gene expression in Bacillus subtilis.
    Jared T Winkelman, Anna C Bree, and Daniel B Kearns

    Mol Microbiol (2013) PMID 23646920

    We show that RemA is a DNA-binding protein that binds to multiple sites upstream of the promoters of both operons and is both necessary and sufficient for transcriptional activation in vivo and in vitro. We further show that SinR negatively regulates eps operon expression by occluding RemA binding a...
  2. Patient preferences for adherence to treatment for osteoarthritis: the MEdication Decisions in Osteoarthritis Study (MEDOS).
    Tracey-Lea Laba, Jo-Anne Brien, and Stephen Jan

    BMC Musculoskelet Disord 14(1):160 (2013) PMID 23647688

    This study has characterised the complexity of medication-taking decisions that potentially underpin intentional non-adherent behaviour for people with symptomatic OA. In particular, medication risks and cost were important and ought to be borne into considerations in interpreting clinical trial evi...
    PDF not found
  3. Long-Term Follow-Up on Affinity Maturation and Memory B-Cell Generation in Patients with Common Variable Immunodeficiency.
    V Ballegaard, H Permin, and L Schejbel

    J Clin Immunol (2013) PMID 23649616

    Switched memory B cells and levels of SHM were not consistently stable markers in a long-term follow-up setting. At a given time during follow-up, 60 % of the patients were assigned to the EUROclass group SmB- (less than 2 % switched memory B cells), but only 23 % were consistently assigned to th...